Microbiology Spectrum (Dec 2023)

Significant increase in the prevalence of Panton–Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, particularly the USA300 variant ΨUSA300, in the Japanese community

  • Hiroshi Kaneko,
  • Miki Kanai,
  • Takumi Saito,
  • Yuka Yanagi,
  • Hana Kobayashi,
  • Rikuto Kurihara,
  • Masami Ikeda,
  • Osamu Nemoto,
  • Naoko Baba,
  • Yasushi Matsuzaki,
  • Daisuke Sawamura,
  • Fumiko Shimoe,
  • Yoichi Inaba,
  • Yoko Kobayashi,
  • Satoru Kawasaki,
  • Toru Ueki,
  • Sakae Funatsu,
  • Shigeho Shirahama,
  • Misao Oba,
  • Takaya Hasegawa,
  • Hirotoshi Furukawa,
  • Toshiko Miyata,
  • Masaaki Isonokami,
  • Shigeru Fujita,
  • Hidemasa Nakaminami

DOI
https://doi.org/10.1128/spectrum.01248-23
Journal volume & issue
Vol. 11, no. 6

Abstract

Read online

ABSTRACT USA300, a major Panton–Valentine leukocidin (PVL)-producing methicillin-resistant Staphylococcus aureus (MRSA) clone associated with skin and soft tissue infections (SSTIs), carries a type IV staphylococcal cassette chromosome mec (SCCmec) element. Recently, a USA300 variant, ΨUSA300, with a 12-bp deletion of ccrB2 in the SCCmec element, was identified in Japan by Takadama et al. (15). To understand the current status of PVL-positive MRSA in the community, a nationwide surveillance of MRSA isolated from outpatients at dermatology departments was conducted. This study included 1,619 outpatients who visited dermatology departments at 22 healthcare facilities in 11 prefectures in Japan between 2018 and 2021; S. aureus were isolated from these outpatients. Molecular epidemiological analysis was performed using PCR, SCCmec and spa typing, pulsed-field gel electrophoresis, multilocus sequence typing, and antimicrobial susceptibility testing. A total of 980 S. aureus were isolated, 293 of which were identified as MRSA. Among MRSA isolates, PVL genes were detected in 18 of 63 (28.6%) in 2018, 34 of 85 (40.0%) in 2019, 29 of 65 (44.6%) in 2020, and 40 in 80 (50.0%) in 2021. Among the PVL-positive MRSA, 16 of 121 (13.2%) and 94 of 121 (77.7%) isolates were identified as USA300 and ΨUSA300, respectively. ΨUSA300 strains were collected from six prefectures in Japan: Kagawa, Osaka, Tokyo, Kanagawa, Fukushima, and Saitama. ΨUSA300 was isolated more frequently than USA300 from patients with deep-seated SSTIs (P < 0.05). Our findings showed that PVL-positive MRSA isolates were significantly increased in the Japanese community. Furthermore, the USA300 variant ΨUSA300 has emerged as the predominant PVL-positive MRSA clone across the Kanto, Kinki, and Shikoku regions of Japan, and this variant may possess a greater propensity to cause deep-seated SSTIs than in USA300. IMPORTANCE USA300 is an MRSA clone producing PVL, a toxin associated with SSTIs. ΨUSA300 is a USA300 variant recently identified in Japan by Takadama et al. (15). Here, we found that the prevalence rate of PVL-positive MRSA in S. aureus was elevated in the Japanese community, and ΨUSA300 accounted for most of them. ΨUSA300 strains have been isolated from several areas in Japan and were associated with deep-seated SSTIs. This study highlighted the emerging threat posed by ΨUSA300 in Japan.

Keywords